RxSight, Inc. (RXST)
6.44
-0.30
(-4.45%)
USD |
NASDAQ |
Mar 20, 16:00
6.43
-0.01
(-0.16%)
After-Hours: 20:00
RxSight EPS Diluted (Quarterly) : -0.2223 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | -0.1428 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.152M |
| Revenue (Quarterly) | 32.61M |
| Total Expenses (Quarterly) | 41.76M |
| Enterprise Value | 48.67M |
| Gross Profit Margin (Quarterly) | 77.47% |
| Profit Margin (Quarterly) | -28.07% |
| Earnings Yield | -14.80% |
| Normalized Earnings Yield | -14.80 |